Testing the peak plasma levels of Amikacin assesses the drug’s effectiveness. Amikacin is typically prescribed for severe gram-negative infections in all age groups. They demonstrate heightened efficacy when the peak concentration surpasses the minimum inhibitory concentration (MIC) required to inhibit the target organism. Healthcare providers utilize this test to ascertain the drug’s efficacy and bactericidal impact.